Post-Translational Modification

Overview

Post-translational modifications (PTMs) are covalent chemical changes made to peptides and proteins after their synthesis on the ribosome. These modifications vastly expand the functional diversity of the proteome — the approximately 20,000 human protein-coding genes give rise to an estimated 1 million or more distinct proteoforms through combinations of PTMs.

In peptide research, PTMs are relevant both as natural regulatory mechanisms that govern peptide activity and as intentional modifications applied during synthesis to alter peptide properties.

Major Types of Post-Translational Modifications

Phosphorylation

The addition of a phosphate group (-PO4) to serine, threonine, or tyrosine residues by kinase enzymes. Phosphorylation is the most studied PTM and a central mechanism in cellular signaling.

• Effect: Adds negative charge; can activate or inhibit protein function, create binding sites for other proteins, or alter subcellular localization
• Reversibility: Removed by phosphatase enzymes, making it a dynamic on/off switch
• Mass shift: +80 Da per phosphate group, detectable by mass spectrometry
• Prevalence: Estimated 30% of all human proteins are phosphorylated at any given time

Acetylation

The addition of an acetyl group (-COCH3), most commonly to lysine residues or the N-terminus of proteins.

• Histone acetylation — Neutralizes the positive charge of lysine, loosening DNA-histone interactions and generally promoting gene transcription
• N-terminal acetylation — Occurs co-translationally on approximately 80% of human proteins; affects stability and protein-protein interactions
• Lysine acetylation — Also occurs on non-histone proteins, regulating metabolic enzymes, transcription factors, and signaling proteins
• Mass shift: +42 Da

Glycosylation

The attachment of sugar (glycan) chains to proteins. The most complex and diverse PTM, with enormous structural variety in the attached glycans.

• N-linked glycosylation — Glycan attached to asparagine within the consensus sequence Asn-X-Ser/Thr (where X is any amino acid except proline). Occurs in the endoplasmic reticulum.
• O-linked glycosylation — Glycan attached to serine or threonine residues. Occurs in the Golgi apparatus.
• Effects: Influences protein folding, stability, cell-cell recognition, immune evasion, and half-life
• Pharmaceutical relevance: Glycosylation patterns are critical for the efficacy and immunogenicity of biologic drugs

Methylation

The addition of methyl groups (-CH3) to arginine or lysine residues.

• Histone methylation — Can activate or repress gene expression depending on the specific residue and degree of methylation (mono-, di-, or tri-methylation)
• Non-histone methylation — Regulates protein-protein interactions and signaling
• Mass shift: +14 Da per methyl group

Ubiquitination

The covalent attachment of ubiquitin, a 76-amino-acid regulatory protein, to lysine residues of target proteins.

• Mono-ubiquitination — Regulates endocytosis, DNA repair, and gene expression
• Poly-ubiquitination (K48-linked) — Signals proteasomal degradation
• Poly-ubiquitination (K63-linked) — Involved in signaling, DNA repair, and autophagy
• Mass shift: +8.5 kDa per ubiquitin

Disulfide Bond Formation

Covalent bonds between cysteine residues, critical for the structural stability of many secreted proteins and peptides. See also cyclization.

Amidation

C-terminal amidation (replacement of -COOH with -CONH2) occurs in approximately 50% of all known bioactive peptides. Many neuropeptides and hormones require amidation for full biological activity. The amidated form often shows enhanced receptor binding and improved resistance to carboxypeptidase degradation.

PTMs in Peptide Science

Natural Peptide Hormones

Many endogenous peptide hormones undergo PTMs essential for their activity:

• Insulin — Requires disulfide bonds for proper folding and activity
• Oxytocin — Contains a disulfide bond forming a cyclic structure
• GLP-1 — Susceptible to DPP-4 cleavage (a form of proteolytic processing); GLP-1 agonist design specifically addresses this vulnerability
• Alpha-MSH — N-terminal acetylation and C-terminal amidation are required for full potency

Synthetic Peptide Modifications

Peptide chemists intentionally introduce PTM-like modifications to improve peptide properties:

• Acetylation of the N-terminus to block aminopeptidase degradation
• Amidation of the C-terminus to improve receptor binding and protease resistance
• Disulfide bridges to constrain conformation and improve stability
• Phosphorylation to modulate activity for research tool compounds

Detection and Analysis

PTMs are primarily detected and characterized by mass spectrometry, particularly tandem MS (MS/MS), which can identify both the type and location of modifications. HPLC can also reveal PTMs when they alter the chromatographic properties of a peptide.

PTMs and Disease

Aberrant post-translational modifications are implicated in numerous diseases:

• Hyperphosphorylation of tau protein in Alzheimer's disease
• Aberrant glycosylation in cancer cells, affecting immune recognition
• Dysregulated acetylation in metabolic disorders and cancer
• Oxidative modifications (a form of unwanted PTM) in aging and neurodegenerative disease

Understanding PTMs is therefore relevant not only to peptide chemistry but to the broader landscape of disease biology and therapeutic development.

Practical Implications

For researchers working with peptides, awareness of PTMs is important for:

• Recognizing that the "same" peptide may exist in multiple modified forms with different activities
• Understanding why storage conditions matter — oxidation, deamidation, and other unwanted PTMs can occur during storage
• Interpreting mass spectrometry data where unexpected mass shifts may indicate modifications
• Appreciating why synthetic peptides may behave differently from their endogenous counterparts if PTMs present in vivo are absent in the synthetic version